Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Accuray Inc (NASDAQ:ARAY)

5.00
Delayed Data
As of Nov 21
 -0.05 / -0.99%
Today’s Change
3.60
Today|||52-Week Range
6.00
+8.70%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$423.0M

Company Description

Accuray, Inc. is a radiation oncology company. It develops, manufactures and sells precise, innovative treatment solutions, which include cyberKnife and tomo therapy systems, which are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The cyberKnife system is designed to combine continual image guidance technology with a compact linear accelerator, or linac, which has the ability to move in three dimensions according to the treatment plan. The tomotherapy system operates on a ring gantry and combines integrated computed tomography, or CT, imaging with intensity modulated radiation therapy, which is designed to deliver radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.

Contact Information

Accuray, Inc.
1310 Chesapeake Terrace
Sunnyvale California 94089
P:(408) 716-4600
Investor Relations:

Employees

Shareholders

Mutual fund holders48.89%
Other institutional36.67%
Individual stakeholders30.52%

Top Executives

Joshua H. LevinePresident, Chief Executive Officer & Director
Andrew J. KirkpatrickSVP-Global Operations, Research & Development
Kevin WatersChief Financial Officer & Senior Vice President
Darl S. MorelandSenior VP-Regulatory, Quality & Compliance
Alaleh NouriSecretary, Senior Vice President & General Counsel